Gary Rafaloff
@grafaloff
Entrepreneur, business man, family man, sports fan. Parkinson's advocate to advance research and find the cure.
قد يعجبك
2024 report on #Parkinsons drug therapies in the clinical trial pipeline is published Thanks to @InnovationFixer @SueBCal1 @grafaloff @kenpitzer650 @bkfiske & the research team at @CureParkinsonsT And oooh, nice pie chart, instead of that ugly bulls eye content.iospress.com/articles/journ…
Will someone please ask Trump the very simple question "what are black and Hispanic jobs"? #Debates2024 #DebateNight
Another super morning at @WorldPDCongress! First up, Professor @basbloem spoke about the importance of using technology to track progression in Parkinson’s and why we should be moving towards personalised outcomes for patients.
...and one (38.38) on the drug development pipeline for #Parkinsons (by @InnovationFixer, @SueBCal1, @grafaloff, @bkfiske, @MichaelJFoxOrg & the research team at @CureParkinsonsT). See the latest report at @journal_PD: content.iospress.com/articles/journ…
Also a very kind mention of the annual drug development pipeline for #Parkinsons report (McFarthing et al - content.iospress.com/articles/journ…) @InnovationFixer @SueBCal1 @grafaloff @bkfiske @MichaelJFoxOrg @CureParkinsonsT
We want to change the future for those living with Parkinson’s and those yet to be diagnosed - to change attitudes and raise awareness, and to speed up progress in the search for the cure: buff.ly/3NZyqSE #ChangeTheFuture #ParkinsonsTogether
What is the latest update on #Parkinsons drug therapies in the clinical trial pipeline? Explore new findings published in the ‘Journal of Parkinson’s Disease’: bit.ly/3NyOglM
(2/2) The committee, comprising of over 20 world-leading Parkinson’s researchers, will then prioritise the most promising treatments to move them into clinical trial for Parkinson’s. To discover more about the impact of our iLCT programme visit: buff.ly/3Mmr6OY
(1/2) The dedicated International Linked Clinical Trials (iLCT) committee will meet this weekend at Cumberland Lodge, Windsor to evaluate and rank a selection of potentially disease-modifying treatments for Parkinson’s. #ILCT #CureParkinsons #ParkinsonsResearch
(2/2) The main aim of the iLCT programme is to repurpose or reposition existing treatments that have the potential to modify Parkinson’s and progress them into clinical trial for Parkinson’s. To find out more about our iLCT programme head to: buff.ly/3NJOd80
(1/2) In 2012 Cure Parkinson’s set up the International Linked Clinical Trials (iLCT) programme to speed up the search for potential treatments for Parkinson’s. #ILCT #CureParkinsons #ParkinsonsResearch
New report from @sahar__yassine @MahmoodHacan & colleagues identifies #Parkinsons subtypes based on resting-state electroencephalography signatures that may provide a more accurate prognosis in patients & help to stratify subgroups in clinical trials …mentdisorders.onlinelibrary.wiley.com/doi/10.1002/md…
Our 4th annual #Parkinsons disease Clinical Trial Pipeline - 2023 update report is now available prepublished at the Journal of Parkinsons Disease content.iospress.com/articles/journ… @AGKootenay
Our 2023 #Parkinsons clinical trial pipeline update is now available content.iospress.com/articles/journ…
The 2023 update of the #Parkinsons disease drug therapies in the clinical trial pipeline is now available at @journal_PD - from @InnovationFixer @SueBCal1 @grafaloff @bkfiske @MichaelJFoxOrg & the research team at @CureParkinsonsT content.iospress.com/articles/journ…
A fantastic resource for #Parkinsons
Wow! An amazing #openaccess resource from the @MichaelJFoxOrg - their quarterly #Parkinsons Priority Therapeutic Clinical Pipeline Report is now openly available on @ZENODO_ORG zenodo.org/record/7863960…
Digital Health Technologies (DHTs) for Drug Development fda.gov/science-resear…
What goes up and what down: 8 Parkinson's microbiome studies. 'Increased Enterobacteriaceae in 4; decreased Prevotellaceae in 5. Lactobacillaceae up in 4, down in 1.' This is why simply taking a random 'probiotic' could be good or could be bad in my view. link.springer.com/article/10.100…
We couldn't ask for a better advancement in open research. Let's hope all other organizations follow this path! Congratulations @CureParkinsonsT
Comments & critiques are welcomed And for those not keen on the heavy science, the lovely comm.s team at @CureParkinsonsT have also provided a lay summary of the research & justification: cureparkinsons.org.uk/ambroxol-the-s…
So honored to be a co-author and member of the great team that won the "Best Clinical Research" paper published in the Journal of Parkinson's Disease (2020-2021). Thank you JPD for the award! @SueBCal1 @ScienceofPD @InnovationFixer @HelenMatthewsQ
We are proud to announce the 2022 winners of the #ParkinsonPrize: Thomas Beach and Charles Adler win for best basic research paper, and Simon Stott wins for the best clinical research paper published in our 2020-21 content. Read more: tinyurl.com/parkinsonprize…. @basbloem @kalialabs
We are proud to announce the 2022 winners of the #ParkinsonPrize: Thomas Beach and Charles Adler win for best basic research paper, and Simon Stott wins for the best clinical research paper published in our 2020-21 content. Read more: tinyurl.com/parkinsonprize…. @basbloem @kalialabs
United States الاتجاهات
- 1. Seahawks 21.8K posts
- 2. Giants 67.4K posts
- 3. Bills 138K posts
- 4. Bears 60.3K posts
- 5. Jags 6,929 posts
- 6. Daboll 12.1K posts
- 7. Caleb 49.4K posts
- 8. Dart 26.3K posts
- 9. Dolphins 33.1K posts
- 10. Rams 16.9K posts
- 11. Josh Allen 16.2K posts
- 12. Texans 38.5K posts
- 13. Russell Wilson 4,051 posts
- 14. Browns 38.2K posts
- 15. Patriots 108K posts
- 16. Ravens 38.4K posts
- 17. Trevor Lawrence 2,564 posts
- 18. Bryce 15.9K posts
- 19. Henderson 17.7K posts
- 20. Niners 3,341 posts
Something went wrong.
Something went wrong.